| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | Mobile-health Network Solutions: Mobile-health Network Solutions Expands into Cybersecurity with Skylink-Contfinity Partnership, Launching OttterSG Bundled Solution for Clinics in Singapore | 274 | Newsfile | Singapore, Singapore--(Newsfile Corp. - June 23, 2026) - Mobile-health Network Solutions (NASDAQ: MNDR) ("MHNS"), a leading AI-powered digital health platform headquartered in Singapore, today announced... ► Artikel lesen | |
| Do | Mobile-health Network Solutions: Mobile-health Network Solutions Announces Change in Effective Date of Reverse Stock Split | 246 | Newsfile | Singapore, Singapore--(Newsfile Corp. - June 18, 2026) - Mobile-health Network Solutions (NASDAQ: MNDR) ("MNDR" or the "Company"), a leading AI-powered digital health platform, today announced a... ► Artikel lesen | |
| Do | Mobile-health Network Solutions - 6-K, Report of foreign issuer | 3 | SEC Filings | ||
| 09.06. | Mobile-health Network Solutions - 6-K, Report of foreign issuer | 4 | SEC Filings | ||
| MOBILE-HEALTH NETWORK SOLUTIONS Aktie jetzt für 0€ handeln | |||||
| 13.05. | Mobile-health Network Solutions: Mobile-health Network Solutions Enters into Non-Binding Strategic Memorandum to Facilitate Up to US$100 Million in Private Equity Funding for AI-Powered Healthcare Expansion | 335 | Newsfile | Singapore, Singapore--(Newsfile Corp. - May 13, 2026) - Mobile-health Network Solutions (NASDAQ: MNDR) ("MNDR" or the "Company"), a leading AI-powered digital health platform, today announced that... ► Artikel lesen | |
| 13.05. | Mobile-health Network Solutions - 6-K, Report of foreign issuer | 3 | SEC Filings | ||
| 04.05. | Mobile-health Network Solutions signs MOU for $119m investment | 4 | Investing.com | ||
| 04.05. | Mobile-health Network Solutions - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 28.04. | Mobile-health Network Solutions secures $126M investment | 3 | Investing.com | ||
| 28.04. | Mobile-health Network Solutions: Mobile-health Network Solutions and Dato' Stanley Ling Announce Strategic US$126 Million Investment to Build Phased 60 MW AI Data Center Campus | 518 | Newsfile | Singapore, Singapore--(Newsfile Corp. - April 28, 2026) - Mobile-health Network Solutions (NASDAQ: MNDR) ("MNDR" or the "Company"), a leading AI-powered digital health platform, today announced... ► Artikel lesen | |
| 24.04. | MNDR secures 60MW AI data center capacity in Malaysia | 1 | Investing.com | ||
| 24.04. | MNDR erweitert Kapazität für KI-Rechenzentren in Malaysia auf 60 MW | 1 | Investing.com Deutsch | ||
| 24.04. | Mobile-health Network Solutions: Mobile-health Network Solutions Announces Acquisition of Additional 35MW AI Data Centre Capacity, Expanding Total Secured Capacity to 60MW | 474 | Newsfile | Singapore, Singapore--(Newsfile Corp. - April 24, 2026) - Mobile-health Network Solutions (NASDAQ: MNDR) ("MNDR" or the "Company") today announced that it has secured an additional 35 megawatts... ► Artikel lesen | |
| 24.04. | Mobile-health Network Solutions - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 24.04. | Mobile-health Network Solutions - F-1/A, Registration statement for certain foreign private issuers | 1 | SEC Filings | ||
| 17.04. | Mobile-health Network Solutions - F-1/A, Registration statement for certain foreign private issuers | - | SEC Filings | ||
| 13.04. | Mobile-health Network Solutions - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 09.04. | Mobile-health Network Solutions - F-1/A, Registration statement for certain foreign private issuers | 1 | SEC Filings | ||
| 20.03. | Mobile-health Network Solutions übernimmt Rechenzentrumsfirma in Malaysia | 7 | Investing.com Deutsch | ||
| 20.03. | MNDR passt Vereinbarung zur Übernahme von KI-Rechenzentren an | 4 | Investing.com Deutsch |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| HEALWELL AI | 0,500 | +1,63 % | HEALWELL AI informiert über Neuigkeiten aus dem Unternehmen: Annahme der Forschungsergebnisse aus provinzübergreifendem KI-Pilotprojekt beim AMIA-Symposium und Stärkung der Bilanz durch SpaceX-Beteiligung | - HEALWELL hat erfolgreich ein Pilotprojekt zur Bewertung seiner auf DARWEN basierenden KI-Lösungen SMART Summary und SMART Search in mehreren kanadischen Provinzen
abgeschlossen. Das... ► Artikel lesen | |
| INSULET | 126,90 | +4,40 % | DexCom, Insulet gain news Buys at Deutsche Bank despite recent selloff | ||
| LIFEWARD | 7,150 | +1,20 % | Lifeward Ltd.: Lifeward Appoints Dr. Keith D. Rose as Chief Medical Officer to Support Expansion of Neurorehabilitation Portfolio and Advance Biomed Platform | Veteran physician- medical affairs and clinical research leader brings 30 years of rehabilitation medicine experience and deep expertise in neuroscience- mobility technologies, and metabolic disease... ► Artikel lesen | |
| IMUNON | 1,620 | 0,00 % | Imunon, Inc.: IMUNON Announces Data Monitoring Committee Recommends Continuation of Phase 3 OVATION 3 Study Without Modification | On track for enrollment of 80 participants by Q1 2027 Trial is supported by Phase 2 results showing significant improvement in overall survival in women with newly diagnosed advanced ovarian cancer... ► Artikel lesen | |
| LANTHEUS | 93,60 | +0,65 % | XETR NEW INSTRUMENTS AVAILABLE ON XETRA - 04.06.2026 | Folgende Wertpapiere werden in den Handel an folgenden Handelsplätzen (MIC Code) im Quotation Board an der Frankfurter Wertpapierbörse (FWB) aufgenommen. Die Notierung an anderen Handelsplätzen im Quotation... ► Artikel lesen | |
| INSPIRE MEDICAL SYSTEMS | 36,200 | 0,00 % | Evercore ISI stuft Inspire Medical Aktie wegen Kodierungsproblemen herab | ||
| INSPIREMD | 0,630 | -2,33 % | InspireMD Posts Positive CGUARDIANS II Data for CGuard Prime TCAR | ||
| GT BIOPHARMA | 0,490 | -0,18 % | GT Biopharma, Inc.: GT Biopharma Announces First Patient Dosed in Phase 1 Trial of GTB-5550, a B7-H3-Targeted Natural Killer (NK) Cell Engager for Solid Tumors | GTB-5550 is now the 3rd TriKE- to enter the clinic and an expansion into a broader solid tumor opportunity, with the Phase 1 trial likely to focus on prostate cancer patients during the dose escalation... ► Artikel lesen | |
| INOGEN | 5,550 | 0,00 % | Inogen Inc - S-8, Securities to be offered to employees in employee benefit plans | ||
| MYOMO | 1,118 | +0,90 % | Myomo übertrifft Q1-Prognosen, Aktie gibt dennoch nach | ||
| INTELLIGENT BIO SOLUTIONS | 2,270 | -4,62 % | Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Initiates Clinical Study Supporting FDA Clearance and Planned U.S. Market Entry | Interference Study designed to validate system specificity in the presence of potentially interfering substances commonly encountered in real-world settings Company expects to complete the study by... ► Artikel lesen | |
| INCANNEX HEALTHCARE | 3,320 | +2,15 % | Incannex Healthcare: Incannex Receives A$6.0 Million R&D Tax Incentive Refund for FY25, Further Strengthening Balance Sheet and Financial Flexibility | NEW YORK and MELBOURNE, Australia, June 10, 2026 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL) ("Incannex" or the "Company"), a clinical-stage biopharmaceutical company advancing innovative... ► Artikel lesen | |
| GLUCOTRACK | 0,360 | -1,07 % | GlucoTrack, Inc.: Glucotrack Reports First Quarter 2026 Financial Results and Recent Corporate Highlights | Submitted Investigational Device Exemption (IDE) application to the U.S. Food and Drug Administration (FDA) to initiate a U.S. clinical study for fully implantable continuous blood glucose monitoring... ► Artikel lesen | |
| LEXARIA BIOSCIENCE | 0,569 | -2,35 % | Lexaria Bioscience Corp.: Lexaria's Animal Study GLP-1-A26-1 Has Begun Dosing on Schedule | Potentially Valuable Novel Compositions Being InvestigatedLexaria Also Receives Additional New Granted Patent KELOWNA, BC / ACCESS Newswire / June 23, 2026 / Lexaria Bioscience Corp. (NASDAQ:LEXX)... ► Artikel lesen | |
| HEARTFLOW | 34,450 | +1,80 % | Heartflow, Inc. - 8-K, Current Report |